221 related articles for article (PubMed ID: 3000682)
1. Imaging of head and neck tumors with technetium(V)-99m DMSA. A new tumor-seeking agent.
Ohta H; Endo K; Fujita T; Nakashima T; Sakahara H; Torizuka K; Shimizu Y; Ishii Y; Makimoto K; Hata N
Clin Nucl Med; 1985 Dec; 10(12):855-60. PubMed ID: 3000682
[TBL] [Abstract][Full Text] [Related]
2. 99Tcm (v) DMSA and 67Ga-citrate imaging in patients with head and neck squamous carcinoma: a clinical and scintigraphic study.
Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
Nucl Med Commun; 1990 Feb; 11(2):103-10. PubMed ID: 2162508
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.
Ohta H; Endo K; Fujita T; Konishi J; Torizuka K; Horiuchi K; Yokoyama A
Nucl Med Commun; 1988 Feb; 9(2):105-16. PubMed ID: 2838772
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m (v) dimercaptosuccinic acid uptake in patients with head and neck squamous carcinoma: experience in imaging.
Watkinson JC; Lazarus CR; Mistry R; Shaheen OH; Maisey MN; Clarke SE
J Nucl Med; 1989 Feb; 30(2):174-80. PubMed ID: 2544690
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of the uptake of technetium-99m (v) dimercaptosuccinic acid in patients with squamous carcinoma of the head and neck.
Watkinson JC; Clarke SE; Shaheen OH
Clin Otolaryngol Allied Sci; 1987 Dec; 12(6):405-11. PubMed ID: 2832106
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans.
Ohta H; Ishii M; Yoshizumi M; Endo K; Sakahara H; Nakajima T; Yomoda I; Masuda H; Horiuchi K; Hata N
Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320
[TBL] [Abstract][Full Text] [Related]
7. 99Tcm(v)-DMSA planar scintigraphy: does it have a role in the management of patients with head and neck squamous carcinoma?
Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
Nucl Med Commun; 1989 Dec; 10(12):859-70. PubMed ID: 2560154
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m(v) dimercaptosuccinic acid planar scintigraphy in head and neck cancer: clinical, scintigraphic and radiological study.
Watkinson JC; Todd CE; Lazarus CR; Maisey MN; Clarke SE
J Laryngol Otol; 1990 Oct; 104(10):783-9. PubMed ID: 2174074
[TBL] [Abstract][Full Text] [Related]
9. Images of liposarcoma using technetium-99m bleomycin and technetium (V)-99m DMSA.
Ohta H; Shane FI; Endo K; Torizuka K; Horiuchi K; Yokoyama A; Ishii M
Clin Nucl Med; 1986 Dec; 11(12):842-4. PubMed ID: 2434276
[TBL] [Abstract][Full Text] [Related]
10. The detection of nasopharynx carcinoma in technetium-99m (V) dimercaptosuccinic acid SPECT imaging.
Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
Clin Nucl Med; 1993 Apr; 18(4):321-3. PubMed ID: 8386992
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m (v) dimercaptosuccinic acid: a clinical and scintigraphic study in an animal tumour model.
Watkinson JC; Allen S; Lazarus CR; Laws D; Hibbert J; Clarke SE
Clin Otolaryngol Allied Sci; 1990 Dec; 15(6):497-501. PubMed ID: 1963580
[TBL] [Abstract][Full Text] [Related]
12. 99Tcm (v) DMSA: a clinical, planar and SPECT study to evaluate patients with head and neck squamous carcinoma.
Watkinson JC; Lazarus CR; Mistry R; Maisey MN; Clarke SE
Nucl Med Commun; 1990 Feb; 11(2):111-20. PubMed ID: 2162509
[TBL] [Abstract][Full Text] [Related]
13. Soft-tissue tumors: diagnosis with Tc-99m (V) dimercaptosuccinic acid scintigraphy.
Kobayashi H; Sakahara H; Hosono M; Shirato M; Endo K; Kotoura Y; Yamamuro T; Konishi J
Radiology; 1994 Jan; 190(1):277-80. PubMed ID: 8259419
[TBL] [Abstract][Full Text] [Related]
14. What is the optimal imaging time for 99Tcm-(V)-DMSA planar scintigraphy in the detection of squamous carcinoma? A comparative study in humans and in an animal tumour model.
Watkinson JC; Allen S; Lazarus CR; Maisey MN; Clarke SE
Nucl Med Commun; 1989 Oct; 10(10):741-50. PubMed ID: 2559379
[TBL] [Abstract][Full Text] [Related]
15. Imaging of soft tissue tumors with Tc(V)-99m dimercaptosuccinic acid. A new tumor-seeking agent.
Ohta H; Endo K; Fujita T; Nakajima T; Sakahara H; Torizuka K; Shimizu Y; Hata N; Masuda H; Horiuchi K
Clin Nucl Med; 1984 Oct; 9(10):568-73. PubMed ID: 6091971
[TBL] [Abstract][Full Text] [Related]
16. [Tumor imaging using Tc(V)-99m dimercaptosuccinic acid, a newly developed radiopharmaceutical: its clinical usefulness].
Ohta H; Endo K; Koizumi M; Fujita T; Sakahara H; Nakashima T; Torizuka K; Hata N; Masuda H; Yomoda I
Kaku Igaku; 1985 Nov; 22(11):1653-60. PubMed ID: 3007822
[No Abstract] [Full Text] [Related]
17. Ga-67 and Tc-99m (V) DMSA imaging in non-Hodgkin's lymphoma with amyloid tumor.
Ohta H; Arima N; Hama Y; Doi S; Nasi K; Komibuchi T; Shintaku M
Clin Nucl Med; 1995 Nov; 20(11):998-9. PubMed ID: 8565385
[TBL] [Abstract][Full Text] [Related]
18. Spindle cell sarcoma showing concentration of Tc-99m sodium pertechnetate and Tc-99m (V) DMSA.
Halkar RK; Patel MC; Khammash NF
Clin Nucl Med; 1990 Feb; 15(2):126-7. PubMed ID: 2155729
[No Abstract] [Full Text] [Related]
19. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
[TBL] [Abstract][Full Text] [Related]
20. [Scintigraphic imaging of head and neck cancers with 99m technetium (v) dimercaptosuccinic acid. A prospective clinical study].
Heinritz H; Marienhagen J; Wolf F; Schuster B; Stenglein C; Iro H
HNO; 1992 Nov; 40(11):437-41. PubMed ID: 1335446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
